Notice of NIDA's Participation in PAR-15-315 "Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21)"

Notice Number: NOT-DA-17-046

Key Dates
Release Date: July 17, 2017

Related Announcements
PAR-15-315

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute on Drug Abuse (NIDA) will participate, effective immediately, in the Funding Opportunity Announcement (FOA) PAR-15-315 "Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21)"

The following sections of PAR-15-315 have been updated to reflect the participation of NIDA in this Funding Opportunity Announcement (FOA).

Part 1. Overview Information
Components of Participating Organizations
National Institute of Neurological Disorders and Stroke (NINDS)
National Eye Institute (NEI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Environmental Health Sciences (NIEHS)    
National Institute on Drug Abuse (NIDA)

Catalog of Federal Domestic Assistance (CFDA) Number(s) 
93.853, 93.867, 93.846, 93.865, 93.113, 93.279

Part 2. Section VII. Agency Contacts
The following contacts have been added:

Scientific/Research Contact(s)
Kristopher Bough, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-9800
Email: Boughk@nih.gov

Financial/Grants Management Contact(s)
Amy Connolly
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-4457
Email: connolla@mail.nih.gov

All other aspects of this FOA remain the same

Inquiries

Please direct all inquiries to:

Kristopher Bough, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-9800
Email: Boughk@nih.gov